Cargando…

Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk

Detalles Bibliográficos
Autores principales:	Tenedini, Elena, Piana, Simonetta, Toss, Angela, Marino, Marco, Barbieri, Elena, Artuso, Lucia, Venturelli, Marta, Gasparini, Elisa, Mandato, Vincenzo Dario, Marchi, Isabella, Castellano, Sara, Luppi, Mario, Trenti, Tommaso, Cortesi, Laura, Tagliafico, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489180/ https://www.ncbi.nlm.nih.gov/pubmed/36075010 http://dx.doi.org/10.1200/PO.22.00138

Ejemplares similares

BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy
por: Toss, Angela, et al.
Publicado: (2020)

Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies
por: Toss, Angela, et al.
Publicado: (2019)

Characterization of New ATM Deletion Associated with Hereditary Breast Cancer
por: Parenti, Sandra, et al.
Publicado: (2021)

BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
por: Cortesi, Laura, et al.
Publicado: (2021)

The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study
por: Toss, Angela, et al.
Publicado: (2021)

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
por: Toss, Angela, et al.
Publicado: (2021)

iVar, an Interpretation-Oriented Tool to Manage the Update and Revision of Variant Annotation and Classification
por: Castellano, Sara, et al.
Publicado: (2021)

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications
por: Toss, Angela, et al.
Publicado: (2018)

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)
por: Cortesi, L., et al.
Publicado: (2023)

Breast ultrasound in high-risk women
por: Cortesi, Laura, et al.
Publicado: (2019)

Low-level constitutional mosaicism of a de novoBRCA1 gene mutation
por: Friedman, E, et al.
Publicado: (2015)

Personalized Systemic Therapies in Hereditary Cancer Syndromes
por: Mastrodomenico, Luciana, et al.
Publicado: (2023)

Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?
por: Cortesi, Laura, et al.
Publicado: (2021)

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer
por: Alhopuro, Pia, et al.
Publicado: (2020)

Low-level constitutional mosaicism of BRCA1 in two women with young onset ovarian cancer
por: Speight, B., et al.
Publicado: (2022)

Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing
por: Bernardis, Isabella, et al.
Publicado: (2016)

Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2
por: Hidalgo Mayoral, Irene, et al.
Publicado: (2023)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

Exceptional response to lurbinectedin and irinotecan in BRCA-mutated platinum-resistant ovarian cancer patient: a case report
por: Cortesi, Laura, et al.
Publicado: (2022)

COVID-19: room for treating T cell exhaustion?
por: Riva, Giovanni, et al.
Publicado: (2020)

Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry
por: Riva, Giovanni, et al.
Publicado: (2021)

PRAKRTIVADA OR INHERITENT CONSTITUTION OF AN INDIVIDUAL
por: Pandya, M. M.
Publicado: (1982)

Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes
por: Toss, Angela, et al.
Publicado: (2015)

COVID-19: more than a cytokine storm
por: Riva, Giovanni, et al.
Publicado: (2020)

BRCA mutation carriers’ perceptions on postmenopausal hormone therapy: An Italian study
por: Grandi, Giovanni, et al.
Publicado: (2021)

Management of PALB2‐associated breast cancer: A literature review and case report
por: Toss, Angela, et al.
Publicado: (2023)

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
por: Toss, Angela, et al.
Publicado: (2017)

Mosaic trisomy 13 and constitutional delay in puberty
por: Eltayeb, Sara Yousif Hussein, et al.
Publicado: (2022)

Mitochondrial inheritance is mediated by microtubules in mammalian cell division
por: Lawrence, Elizabeth, et al.
Publicado: (2013)

The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation
por: Toss, Angela, et al.
Publicado: (2016)

Constitutional Mosaic Epimutations - a hidden cause of cancer?
por: Lønning, Per E., et al.
Publicado: (2019)

Inheritance of Pigeonpea Sterility Mosaic Disease Resistance in Pigeonpea
por: Daspute, Abhijit, et al.
Publicado: (2014)

Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature
por: Santandrea, Giacomo, et al.
Publicado: (2021)

Somatic APC mosaicism and oligogenic inheritance in genetically unsolved colorectal adenomatous polyposis patients
por: Ciavarella, Michele, et al.
Publicado: (2018)

Genomic mosaicism in the pathogenesis and inheritance of a Rett syndrome cohort
por: Zhang, Qingping, et al.
Publicado: (2018)

Lifestyle Intervention on Body Weight and Physical Activity in Patients with Breast Cancer Can Reduce the Risk of Death in Obese Women: The EMILI Study
por: Cortesi, Laura, et al.
Publicado: (2020)

Male mammary myofibroblastoma: Two case reports and brief review of literature
por: Venturelli, Marta, et al.
Publicado: (2020)

Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study
por: Toss, Angela, et al.
Publicado: (2021)

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials
por: Omarini, Claudia, et al.
Publicado: (2020)

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
por: Rebbeck, Timothy R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_td7d58po8chq8setd8mte34a3n